Washington Nc Newspaper

BioPontis Alliance Enters into Translational Technology Development Agreement ...

RALEIGH, N.C. & WASHINGTON--( EON: Enhanced Online News )--BioPontis Alliance, LLC, announced today at the 2011 BIO International Convention in Washington DC that it has entered into a Translational Technology Development agreement with Pfizer Inc. The agreement is an element of BioPontis Alliance’s unique business model which combines translational drug research with its own asset based investment fund. Pfizer is the second leading pharmaceutical company to join the alliance structure at BioPontis Alliance, which is a first-in-kind vehicle for capturing innovative science from academia and doing the necessary work to potentially translate discoveries into drug candidates for further development by pharmaceutical companies like Pfizer.

BioPontis Alliance has established research alliances with a group of the nation’s leading academic research institutes, in which BioPontis Alliance searches for innovative science that has the potential to be translated into new treatments for cancer, neurology, inflammation and infectious diseases. BioPontis Alliance currently has agreements with a consortium of leading universities and research institutions including New York University, Columbia University, Memorial Sloan-Kettering Cancer Center, University of Pennsylvania, University of North Carolina (Chapel Hill), University of Virginia and University of Florida.

“The gap between early science and translation into clinical applications presents an opportunity for industry and academia to collaborate in an unprecedented manner,” says Uwe Schoenbeck, Chief Scientific Officer for External R&D at Pfizer. “We at Pfizer are committed to establishing productive relationships with academic scientists, and the BioPontis agreement complements other innovation initiatives at Pfizer, such as our Centers for Therapeutic Innovation. We are excited to have the opportunity to work alongside BioPontis Alliance as they conduct critical translational research and development on promising new science.”

Under the agreement, Pfizer will provide guidance on the BioPontis Alliance product portfolio to help ensure that BioPontis Alliance’s investment in particular development programs is in alignment with clinical need and market demand. Pfizer will have the opportunity to provide BioPontis Alliance with scientific and medical advice on the design of experiments and the product profile needed for a successful product development strategy. In addition, Pfizer will have an opportunity to evaluate and license early-stage therapeutic opportunities.

Beaufort County Now in Washington NC » Washington Police ...

News Release

    Washington Police Department is limited in the information it can release about the current location of Mr. Gautier. After the situation from yesterday was resolved he was transported to Beaufort county Medical Center. No further details can be released about his medical situation. Investigation into the incident is ongoing and charges will be completed upon consultation with the D.A. and other entities. Washington Police Department would like to thank all of the assisting agencies (Beaufort County Sheriff�s Office, NC State Bureau of Investigation, Washington Fire/Rescue/EMS, A.L.E. and Washington Utilities, as well as the local residents, and media for their cooperation which lead to a peaceful resolution to the events on Wednesday.

Lt. William H.

Dictionary of North Carolina biography

Cold War America, 1946 to 1990

Who's who of Pulitzer Prize winners

Frank Porter Graham and the 1950 Senate race in North Carolina

The New York Times Almanac 2002